Here are the top 25 cancer stories Becker's reported on in 2023:
The Latest
Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.
Syracuse, N.Y.-based St. Joseph's Health is partnering with Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., to bring more oncology services to local residents.
Indianapolis-based Community Health Network is adding two cancer treatments to its cancer center thanks to a partnership with Houston-based MD Anderson Cancer Center, Inside Indiana Business reported Dec. 14.
UChicago Medicine has received a $20 million gift to support the development of a cancer care and research facility that's slated to open in 2027.
A new year means new goals and strategies for cancer centers across the nation.
Kennewick, Wash.-based Trios Health will temporarily end its medical oncology services Dec. 13 due to staff shortages, the Tri-City Herald reported.
New Brunswick-based Rutgers Cancer Institute of New Jersey and RWJBarnabas Health in West Orange, N.J., have named Louise Ligresti, MD, as chief of cancer survivorship.
A recent analysis found multiple myeloma patients in real-world settings have worse outcomes from standard regimens compared to those reported in clinical trials.
A study by New York City-based NYU Langone Health found a combination of a drug and protein fragment that prevents the growth of blood cancer cells.